医疗监测者在临床试验中的重要作用
Gerald L Klein1,2, Elizabeth Barabash3, Roger E Morgan4
1Medical Affairs, MedSurgPI, Pittsboro, USA.
Cureus
|October 17, 2025
概括
医疗监测器 (MM) 对于临床试验中的患者安全和科学完整性至关重要. 它们的独立监管保护它们免受偏见和风险的影响,这使得它们对于药物和设备开发至关重要.
科学领域:
- 临床试验 临床试验
- 监管科学 监管科学
- 生物技术是生物技术.
背景情况:
- 医疗监测器 (MM) 对于临床试验中的患者安全,监管合规性和科学完整性至关重要.
- 它们在早期的制药,生物技术和医疗器械开发中发挥的作用尤其重要.
- 货币市场作为独立的保护措施,防止偏见和意外风险.
研究的目的:
- 概述医疗监测 (MM) 角色的理由,责任和操作价值.
- 强调MM在文档审查,实时安全监督和监管调整方面的功能.
- 论证MM的独立性和客观性是战略业务的必要性.
主要方法:
- 编辑审查医疗监督角色.
- 分析MM的职责,包括文件审查和安全监督.
- 纳入案例研究和当前的最佳实践.
主要成果:
- 在确保患者安全和监管合规方面,MM的作用至关重要.
- MMs提供必要的独立监督,减轻偏见和风险.
- 他们的职能包括文档审查,实时安全监控和监管调整.
结论:
- 医疗监督员的独立性和客观性至关重要.
- MMs是一个战略性的业务必要性,而不仅仅是监管要求.
- 有效的MM实施提高了临床试验的完整性和成功.
相关概念视频
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Therapeutic Drug Monitoring: Overview and Classification
306
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
306
Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Therapeutic Drug Monitoring: Drug Analysis Methods
176
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
176
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


